{
    "SPADE_UN_14376": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_14376",
            "Peptide Name": "Indolicidin [P3,7,10A,R12,13P]",
            "Source": "Synthetic construct(derived from Indolicidin)",
            "Family": "Retroviridae",
            "Gene": "Not found",
            "Sequence": "ILAWKWAWWAWPP",
            "Sequence Length": 13,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.15482931]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=54 µM);inhibition of strand transfer catalyzed by integrase(IC50=41 µM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "HIV Integrase",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidtion",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C92H115N19O14",
            "Mass": 1711.02,
            "PI": 8.75,
            "Net Charge": 1,
            "Hydrophobicity": 0.16,
            "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour",
            "Mechanism of action": "The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.",
            "Literature": [
                {
                    "Title": "Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.",
                    "Pubmed ID": "15482931",
                    "Reference": "Bioorg Med Chem Lett. 2004 Nov 15;14(22)5595-8.",
                    "Author": "Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15482931"
                },
                {
                    "Title": "Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin",
                    "Pubmed ID": "",
                    "Author": "Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP"
                }
            ],
            "Frequent Amino Acids": "WAP",
            "Absent Amino Acids": "CDEFGHMNOQRSTUVY",
            "Basic Residues": 1,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 12,
            "Polar Residues": 4,
            "Positive Residues": 1,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_18549",
                    "Similarity": 0.9166666666666666,
                    "Sequence": "ILAWKWAWWAWR"
                },
                {
                    "SPADE_ID": "SPADE_N_02454",
                    "Similarity": 0.8461538461538461,
                    "Sequence": "ILAWKWAWWAWRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_25161",
                    "Similarity": 0.8461538461538461,
                    "Sequence": "GILAWKWAWWAWRR"
                }
            ]
        }
    }
}